Why is Transgene Biotek falling/rising?

As of 22-Sep, Transgene Biotek Ltd's stock price is currently at 3.95, reflecting an increase of 0.11 or 2.86%. The stock has shown a trend reversal by gaining after two consecutive days of decline, outperforming its sector by 3.29%. However, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend overall. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 17.32% compared to the 5-day average. The stock has experienced significant declines over the past year, with a 50.56% drop, while the year-to-date performance shows a decline of 42.17%.
In the broader market context, the stock's short-term performance over the past week has been negative at -4.82%, contrasting with the Sensex, which has gained 0.46% during the same period. This underperformance against the benchmark highlights the challenges faced by Transgene Biotek Ltd in attracting investor interest despite today's positive movement. The overall market sentiment appears to be more favorable than that of the stock, which has struggled significantly over longer periods, as evidenced by its year-to-date and one-year returns compared to the Sensex.